Basel, Switzerland

Elias Ndzie

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elias Ndzie. Retrieved from https://idiyas.com/inventor/elias-ndzie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Elias Ndzie in Basel, Switzerland

Introduction

Elias Ndzie is a distinguished inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in developing novel solutions for medical challenges. With a notable patent to his name, Ndzie exemplifies the qualities of innovation and dedication in the fast-paced world of scientific research.

Latest Patents

Elias Ndzie holds a patent related to a new crystalline form of the acetate salt. This invention has promising applications in the prevention and treatment of transplant rejection, addressing a critical need in the medical community. Such advancements are vital for improving patient outcomes in transplantation procedures.

Career Highlights

Currently, Elias Ndzie is affiliated with Novartis AG, a global healthcare company known for its innovative medicines. His work revolves around the intersection of pharmaceutical development and patient care, showcasing his commitment to advancing therapeutic options.

Collaborations

Elias has collaborated with talented professionals such as Piotr Henryk Karpinski and Stéphanie Monnier. Together, they contribute to groundbreaking research and development, supporting Novartis AG's mission to deliver impactful health solutions.

Conclusion

Elias Ndzie's journey as an inventor highlights the importance of innovation in healthcare. His accomplishments, including his patent and collaborations, stand as a testament to his expertise and dedication. As he continues to work at Novartis AG, the future looks promising for further advancements in the medical field that could improve patients' lives worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…